News
Wall Street Analysts Think Natural Gas Services (NGS) Could Surge 38.57%: Read This Before Placing a Bet
Shares of Natural Gas Services (NGS) have gained 12.3% over the past four weeks to close the last trading session at $26.16, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts Predict a 39.94% Upside in The Pennant Group (PNTG): Here's What You Should Know
Shares of The Pennant Group, Inc. (PNTG) have gained 8.8% over the past four weeks to close the last trading session at $24.01, but there could still be a solid upside left in the stock if
Should You Buy CVB Financial (CVBF) After Golden Cross?
After reaching an important support level, CVB Financial Corporation (CVBF) could be a good stock pick from a technical perspective. CVBF recently experienced a "golden cross" event, which saw its
Wall Street Analysts Think Deluxe (DLX) Could Surge 36.06%: Read This Before Placing a Bet
Deluxe (DLX) closed the last trading session at $19.66, gaining 26.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
How Much Upside is Left in Q2 Holdings (QTWO)? Wall Street Analysts Think 29.72%
Q2 Holdings (QTWO) closed the last trading session at $78.73, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Beyond (BBBY) Now Trades Above Golden Cross: Time to Buy?
Beyond, Inc. (BBBY) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, BBBY's 50-day simple moving average broke out above its
Wall Street Analysts Believe Syndax (SNDX) Could Rally 112.8%: Here's is How to Trade
Syndax Pharmaceuticals (SNDX) closed the last trading session at $16.33, gaining 63.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet
Passage Bio, Inc. (PASG) closed the last trading session at $7.13, gaining 24.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Does The Beachbody Company (BODI) Have the Potential to Rally 96.55% as Wall Street Analysts Expect?
The Beachbody Company, Inc. (BODI) closed the last trading session at $5.51, gaining 40.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
After Golden Cross, Bar Harbor Bankshares (BHB)'s Technical Outlook is Bright
Bar Harbor Bankshares, Inc. (BHB) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, BHB's 50-day simple moving average broke out
Does Nexxen International Ltd. Sponsored ADR (NEXN) Have the Potential to Rally 53.34% as Wall Street Analysts Expect?
Shares of Nexxen International Ltd. Sponsored ADR (NEXN) have gained 0.1% over the past four weeks to close the last trading session at $10.03, but there could still be a solid upside left in the
Wall Street Analysts Believe TTM (TTMI) Could Rally 27.33%: Here's is How to Trade
Shares of TTM Technologies (TTMI) have gained 2.8% over the past four weeks to close the last trading session at $44.57, but there could still be a solid upside left in the stock if short-term price
Does Arcutis Biotherapeutics (ARQT) Have the Potential to Rally 45.81% as Wall Street Analysts Expect?
Arcutis Biotherapeutics, Inc. (ARQT) closed the last trading session at $15.52, gaining 8.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Y-mAbs Therapeutics, Inc. (YMAB) Now Trades Above Golden Cross: Time to Buy?
After reaching an important support level, Y-mAbs Therapeutics, Inc. (YMAB) could be a good stock pick from a technical perspective. YMAB recently experienced a "golden cross" event, which saw its
Wall Street Analysts Predict a 35.8% Upside in Ranpak Holdings (PACK): Here's What You Should Know
Ranpak Holdings Corp (PACK) closed the last trading session at $5.28, gaining 52.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by
Guardian Pharmacy Services (GRDN)'s Technical Outlook is Bright After Key Golden Cross
Guardian Pharmacy Services, Inc. (GRDN) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GRDN's 50-day simple moving average broke
Wall Street Analysts Believe DoubleDown Interactive (DDI) Could Rally 99.48%: Here's is How to Trade
Shares of DoubleDown Interactive Co., Ltd. Sponsored ADR (DDI) have gained 4.8% over the past four weeks to close the last trading session at $9.65, but there could still be a solid upside left in
Wall Street Analysts Predict a 130.63% Upside in Foghorn Therapeutics (FHTX): Here's What You Should Know
Foghorn Therapeutics Inc. (FHTX) closed the last trading session at $5.06, gaining 1.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts Predict a 41.36% Upside in CI&T (CINT): Here's What You Should Know
Shares of CI&T Inc. (CINT) have gained 2.3% over the past four weeks to close the last trading session at $5.44, but there could still be a solid upside left in the stock if short-term price targets
Should You Buy Arcturus Therapeutics (ARCT) After Golden Cross?
Arcturus Therapeutics Holdings Inc. (ARCT) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ARCT's 50-day simple moving
Wall Street Analysts Believe ARKO (ARKO) Could Rally 32.6%: Here's is How to Trade
Shares of ARKO Corp. (ARKO) have gained 25.3% over the past four weeks to close the last trading session at $5, but there could still be a solid upside left in the stock if short-term price targets
S&T Bancorp (STBA)'s Technical Outlook is Bright After Key Golden Cross
After reaching an important support level, S&T Bancorp, Inc. (STBA) could be a good stock pick from a technical perspective. STBA recently experienced a "golden cross" event, which saw its 50-day
Here's Why Ascentage Pharma Group International - Unsponsored ADR (AAPG) Is a Great 'Buy the Bottom' Stock Now
Shares of Ascentage Pharma Group International - Unsponsored ADR (AAPG) have been struggling lately and have lost 11.3% over the past week. However, a hammer chart pattern was formed in its last
Here's Why XOMA Royalty (XOMA) Is a Great 'Buy the Bottom' Stock Now
Shares of XOMA Royalty (XOMA) have been struggling lately and have lost 5.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the
Wall Street Analysts Think Amneal (AMRX) Could Surge 25.52%: Read This Before Placing a Bet
Shares of Amneal Pharmaceuticals (AMRX) have gained 22.1% over the past four weeks to close the last trading session at $9.56, but there could still be a solid upside left in the stock if short-term


